Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Enteric coating is a possible cause of aspirin resistance.

Kapoor JR.

J Am Coll Cardiol. 2008 Oct 7;52(15):1276-7; author reply 1277. doi: 10.1016/j.jacc.2008.06.040. No abstract available.

2.

[Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].

Mani H, Lindhoff-Last E.

Pharm Unserer Zeit. 2009;38(4):342-50. doi: 10.1002/pauz.200900324. Review. German. No abstract available.

PMID:
19572355
3.

Aspirin resistance.

Michelson AD.

Pathophysiol Haemost Thromb. 2006;35(1-2):5-9. Review. No abstract available.

PMID:
16855339
4.

[Variable platelet response to aspirin and new therapeutic targets].

Richard S, Toussaint-Hacquard M, Lecompte T.

J Mal Vasc. 2009 Feb;34(1):16-25. doi: 10.1016/j.jmv.2008.10.009. Epub 2008 Dec 24. Review. French.

PMID:
19110389
5.

Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.

Ben-Dor I, Kleiman NS, Lev E.

Am J Cardiol. 2009 Jul 15;104(2):227-33. doi: 10.1016/j.amjcard.2009.03.022. Epub 2009 May 13. Review.

PMID:
19576352
6.

Variable platelet responsiveness to aspirin and clopidogrel: role of platelet function and genetic polymorphism testing.

Azam SM, Jozic J.

Transl Res. 2009 Dec;154(6):309-13. doi: 10.1016/j.trsl.2009.09.011. Epub 2009 Oct 14. Review.

PMID:
19931197
7.

Aspirin resistance in cardiovascular disease: pathogenesis, diagnosis and clinical impact.

Papathanasiou A, Goudevenos J, Tselepis AD.

Curr Pharm Des. 2009;15(10):1085-94. Review.

PMID:
19355950
8.

The genetics of antiplatelet drug resistance.

Feher G, Feher A, Pusch G, Lupkovics G, Szapary L, Papp E.

Clin Genet. 2009 Jan;75(1):1-18. doi: 10.1111/j.1399-0004.2008.01105.x. Epub 2008 Nov 29. Review.

PMID:
19067731
9.

[Aspirin resistance].

Miyata S, Miyata T, Kada A, Nagatsuka K.

Brain Nerve. 2008 Nov;60(11):1357-64. Review. Japanese.

PMID:
19069170
10.

[Study of variability in response to aspirin and clopidogrel: clinical and/or biological resistance?].

Samama MM, Elalamy I.

Ann Pharm Fr. 2009 Jul;67(4):265-71. doi: 10.1016/j.pharma.2009.05.002. Epub 2009 Jul 3. Review. French.

PMID:
19596100
11.

[Clopidogrel resistance].

Güray Y, Güray U, Korkmaz S.

Anadolu Kardiyol Derg. 2009 Jun;9(3):231-7. Review. Turkish.

12.

[Resistance to platelet antiaggregants: the cardiologist's point of view].

Metz D, Hézard N, Duval S, Tassan-Mangina S, Deschildre A, Brasselet C, Nguyen P.

J Mal Vasc. 2009 Feb;34(1):26-33. doi: 10.1016/j.jmv.2008.11.005. Epub 2009 Jan 6. Review. French.

PMID:
19128908
13.

Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance.

Bonvini RF, Reny JL, Mach F, Zeller T, Fontana P.

Curr Vasc Pharmacol. 2009 Apr;7(2):198-208. Review.

PMID:
19356003
14.

Variability in responsiveness to oral antiplatelet therapy.

Angiolillo DJ.

Am J Cardiol. 2009 Feb 2;103(3 Suppl):27A-34A. doi: 10.1016/j.amjcard.2008.11.020. Review.

PMID:
19166710
15.

Aspirin resistance: focus on clinical endpoints.

Pusch G, Feher G, Kotai K, Tibold A, Gasztonyi B, Feher A, Papp E, Lupkovics G, Szapary L.

J Cardiovasc Pharmacol. 2008 Dec;52(6):475-84. doi: 10.1097/FJC.0b013e31818eee5f. Review.

PMID:
19034037
16.

[Resistance to desaggregants: causes, clinical implication, methods of diagnosis and correction].

Kremneva LV, Shalaev SV.

Ter Arkh. 2008;80(12):89-95. Review. Russian. No abstract available.

PMID:
19227916
17.

Platelet function testing and implications for clinical practice.

Collet JP, Montalescot G.

J Cardiovasc Pharmacol Ther. 2009 Sep;14(3):157-69. doi: 10.1177/1074248409339309. Review.

PMID:
19721130

Supplemental Content

Support Center